From high-level cancer research to fertilizer manufacturing, Oregon’s wide-ranging bioscience industry accounted for $3.5 billion of economic activity in 2007, or about 2.2 percent of the state’s GDP.
See the full article on the Portland Business Journal Website. Please note: You have to be a paid print subscriber to the Portland Business Journal to see the full article.
Blue Reference, Inc. has launched a consortium, in cooperation with global pharmaceutical companies, to identify superior methods for delivering Quality by Design via a comprehensive software solution.
Move over Big Three. Little Biotech is joining you in seeking federal assistance.
The South Waterfront development links OMSI with higher-ed institutions
The Oregon Translational Research and Drug Development Institute (OTRADI) announced today that it has experimentally tested and identified a significant number of biological compounds with previously unknown abilities to block more than 75 percent of the growth of some fungi, parasites that cause malaria, and some bacteria, such as Staphylococcus aureus (Staph A) and Escherichia (E coli). Oregon’s newest laboratory achieved these results in its first six weeks of operation.